Suzuki, S., Otani, T., Ikeda, K., Tamura, N., & Morimoto, S. Additional benefits of belimumab in chronic phase of systemic lupus erythematosus and efficacy of tacrolimus combination therapy. Taylor & Francis Group.
Chicago Style (17th ed.) CitationSuzuki, Satoshi, Tomoya Otani, Keigo Ikeda, Naoto Tamura, and Shinji Morimoto. Additional Benefits of Belimumab in Chronic Phase of Systemic Lupus Erythematosus and Efficacy of Tacrolimus Combination Therapy. Taylor & Francis Group.
MLA (9th ed.) CitationSuzuki, Satoshi, et al. Additional Benefits of Belimumab in Chronic Phase of Systemic Lupus Erythematosus and Efficacy of Tacrolimus Combination Therapy. Taylor & Francis Group.
Warning: These citations may not always be 100% accurate.